Issue link: https://beckershealthcare.uberflip.com/i/1482786
54 INNOVATION 5 health systems launching hospital-at- home programs By Naomi Diaz H ere are five health systems that launched "hospi- tal-at-home" programs since July 26. 1. Fort Myers, Fla.-based Lee Health partnered with telehealth and remote patient monitoring Health Recovery Solutions to create a virtual health program for patients with congestive heart failure, chronic obstructive pulmonary disease, hypertension and post cardio-thoracic surgery patients. The aim of the program is to decrease hospital readmissions and reduce unnecessary emergency room visits. 2. Kansas City, Mo.-based Saint Luke's Health System partnered with Medically Home to create a hospital- at-home program that provides high-acuity care at home for patients. The program, dubbed Hospital In Your Home, provides care at-home to a wide range of conditions that would traditionally require inpatient hospitalization. 3. Mannington Township, N.J.-based Salem Medical Center partnered with in-home medical care provider Sena Health to launch an acute in-home care program. The program, dubbed Salem Acute Care at Home, will allow patients to remain at home while receiving hospital-level care from physicians and nurses. 4. Yale New Haven (Conn.) Health is planning to launch a home infusion program Sept. 9. As part of the program, patients will receive infusion treatments at home for conditions that typically used to require a visit to a hospital or infusion clinic. 5. Rochester, Minn.-based Mayo Clinic is partnering with health tech company WizeCare to develop an at-home cardiac rehabilitation program. The program will guide patients in their daily exercise routines and monitor heart rate, cardiopulmonary fitness levels and oxygen consumption. The aim is to identify any life-threatening cardiac events early and improve adherence to the rehab program. n BJC HealthCare leads $6M investment in data analytics startup By Giles Bruce A fter leading a $6 million investment for CuriMeta, St. Louis-based BJC HealthCare is embarking on a collaboration with the analytics startup that aims to use deidentified patient data to cure illnesses like heart disease, cancer and neurodegenerative conditions. The funding round was co-led by BJC partner Washington University School of Medicine, also based in St. Louis. "We have the tools to shape our future," said Richard Liekweg, president and CEO of BJC HealthCare, in an Aug. 30 university news release. "It's our responsibility to use this unparalleled data platform to chart elusive territory where curing, preventing and predicting deadly or chronic illness is possible." CuriMeta says it's creating a secure platform to share real- world data sets with life science companies that the three collaborators will jointly review and select. "For example, such data can help find new uses for existing drugs, and those therapies can be delivered to market quickly and more cost-efficiently, complementing our existing strengths in drug discovery and clinical research, and in turn, providing more options to maintain health and treat disease," stated Philip Payne, PhD, chief data scientist and director of the Institute for Informatics at Washington University School of Medicine. The collaborators will work to protect patient privacy, in part by using artificial intelligence to build "synthetic" data sets. "Manufacturers invest billions each year to advance the science of medicine, yet there are still gaps in our understanding of the best way to diagnose, prevent and treat disease," stated CuriMeta founder and CEO Davis Walp. The startup plans to provide "comprehensive, secure and high-quality health data to researchers in order to ultimately prove the safety, efficacy and clinical value of new or existing diagnostics and treatments," said Darren Brodeur, CuriMeta's chief commercial officer, in an Aug. 30 company news release. n